Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 24 results.
User Information
Export Records
  1. 1.   FIV diversity: FIV(Ple) subtype composition may influence disease outcome in African lions
  2. Troyer, J. L.; Roelke, M. E.; Jespersen, J. M.; Baggett, N.; Buckley-Beason, V.; MacNulty, D.; Craft, M.; Packer, C.; Pecon-Slattery, J.; O'Brien, S. J.
  3. Veterinary Immunology and Immunopathology. 2011, Oct; 143(3-4): 338-346.
  1. 2.   A Single Polymorphism in HIV-1 Subtype C SP1 Is Sufficient To Confer Natural Resistance to the Maturation Inhibitor Bevirimat
  2. Lu, W. X.; Salzwedel, K.; Wang, D.; Chakravarty, S.; Freed, E. O.; Wild, C. T.; Li, F.
  3. Antimicrobial Agents and Chemotherapy. 2011, Jul; 55(7): 3324-3329.
  1. 3.   Effect of Mutations in the Human Immunodeficiency Virus Type 1 Protease on Cleavage of the gp41 Cytoplasmic Tail
  2. Waheed, A. A.; Ablan, S. D.; Sowder, R. C.; Roser, J. D.; Schaffner, C. P.; Chertova, E.; Freed, E. O.
  3. Journal of Virology. 2010, Mar; 84(6): 3121-3126.
  1. 4.   Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: Evidence for Vpu dependence
  2. Waheed, A. A.; Ablan, S. D.; Soheilian, F.; Nagashima, K.; Ono, A.; Schaffner, C. P.; Freed, E. O.
  3. Journal of Virology. 2008 82(19): 9776-9781.
  1. 5.   HIV/AIDS: in search of an animal model
  2. Ambrose, Z.; KewalRamani, V. N.; Bieniasz, P. D.; Hatziioannou, T.
  3. Trends in Biotechnology. 2007, Aug; 25(8): 333-337.
  1. 6.   Phenotypic and genotypic comparisons of human T-cell leukemia virus type I reverse transcriptases from infected T-cell lines and patient samples
  2. Mitchell, M. S.; Bodine, E. T.; Hill, S.; Princler, G.; Lloyd, P.; Mitsuya, H.; Matsuoka, M.; Derse, D.
  3. Journal of Virology. 2007, May; 81(9): 4422-4428.
  1. 7.   HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease
  2. Waheed, A. A.; Ablan, S. D.; Roser, J. D.; Sowder, R. C.; Schaffner, C. P.; Chertova, E.; Freed, E. O.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, May; 104(20): 8467-8471.
  1. 8.   Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27
  2. Fakruddin, J. M.; Lempicki, R. A.; Gorelick, R. J.; Yang, J.; Adelsberger, J. W.; Garcia-Pineres, A. J.; Pinto, L. A.; Lanes, H. C.; Imamichi, T.
  3. Blood. 2007, Mar; 109(5): 1841-1849.
  1. 9.   The inner loop of tetraspanins CD82 and CD81 mediates interactions with human T cell lymphotrophic virus type 1 Gag protein
  2. Mazurov, D.; Heidecker, G.; Derse, D.
  3. Journal of Biological Chemistry. 2007, Feb; 282(6): 3896-3903.
  1. 10.   Long lasting control and lack of pathogenicity of the attenuated Rev-independent SIV in rhesus macaques
  2. von Gegerfelt, A. S.; Alicea, C.; Valentin, A.; Morrow, M.; van Rompay, K. K. A.; Ayash-Rashkovsky, M.; Markham, P.; Else, J. G.; Marthas, M. L.; Pavlakis, G. N.; Ruprecht, R. M.; Felber, B. K.
  3. Aids Research and Human Retroviruses. 2006, Jun; 22(6): 516-528.
  1. 11.   Sensitive phenotypic detection of minor drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants
  2. Nissley, D. V.; Halvas, E. K.; Hoppman, N. L.; Garfinkel, D. J.; Mellors, J. W.; Strathern, J. N.
  3. Journal of Clinical Microbiology. 2005, NOV; 43(11): 5696-5704.
  1. 12.   Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus
  2. Yuste, E.; Johnson, W.; Pavlakis, G. N.; Desrosiers, R. C.
  3. Journal of Virology. 2005, OCT; 79(19): 12455-12463.
  1. 13.   A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors
  2. Daelemans, D.; Pannecouque, C.; Pavlakis, G. N.; Tabarrini, O.; De Clercq, E.
  3. Molecular Pharmacology. 2005, MAY; 67(5): 1574-1580.
  1. 14.   Infectious transmission and replication of human T-cell leukemia virus type 1
  2. Derse, D.; Heidecker, G.; Mitchell, M.; Hill, S.; Lloyd, P.; Princler, G.
  3. Frontiers in Bioscience. 2004, SEP 1; 9: 2495-2499.
  1. 15.   Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicity
  2. Xiao, X. D.; Phogat, S.; Shu, Y.; Phogat, A.; Chow, Y. H.; Wei, O. L.; Goldstein, H.; Broder, C. C.; Dimitrov, D. S.
  3. Vaccine. 2003 21(27-30): 4275-4284.
  1. 16.   Rev-independent simian immunodeficiency virus strains are nonpathogenic in neonatal macaques
  2. von Gegerfelt, A. S.; Liska, V.; Li, P. L.; McClure, H. M.; Horie, K.; Nappi, F.; Montefiori, D. C.; Pavlakis, G. N.; Marthas, M. L.; Ruprecht, R. M.; Felber, B. K.
  3. Journal of Virology. 2002 76(1): 96-104.
  1. 17.   Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors
  2. Derse, D.; Hill, S. A.; Lloyd, P. A.; Chung, H. K.; Morse, B. A.
  3. Journal of Virology. 2001 75(18): 8461-8468.
  1. 18.   Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection
  2. Alexander, L.; Weiskopf, E.; Greenough, T. C.; Gaddis, N. C.; Auerbach, M. R.; Malim, M. H.; O'Brien, S. J.; Walker, B. D.; Sullivan, J. L.; Desrosiers, R. C.
  3. Journal of Virology. 2000 74(9): 4361-4376.
  1. 19.   N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates
  2. Chabot, D. J.; Chen, H.; Dimitrov, D. S.; Broder, C. C.
  3. Journal of Virology. 2000 74(9): 4404-4413.
  1. 20.   Defective and wild-type human T-cell leukemia virus type I proviruses: Characterization of gene products and trans-interactions between proviruses
  2. Shuh, M.; Hill, S. A.; Derse, D.
  3. Virology. 1999 262(2): 442-451.
  1. 21.   Comparisons of defective HTLV-I proviruses predict the mode of origin and coding potential of internally deleted genomes
  2. Hill, S. A.; Shuh, M.; Derse, D.
  3. Virology. 1999 263(2): 273-281.
  1. 22.   Hiv Type 1 Protease Inhibitors Fail to Inhibit Htlv-I Gag Processing in Infected Cells
  2. Pettit, S. C.; Sanchez, R.; Smith, T.; Wehbie, R.; Derse, D.; Swanstrom, R.
  3. Aids Research and Human Retroviruses. 1998 14(11): 1007-1014.
  1. 23.   X-I and X-Ii Open Reading Frames of Htlv-I Are Not Required For Virus Replication or For Immortalization of Primary T-Cells in Vitro
  2. Derse, D.; Mikovits, J.; Ruscetti, F.
  3. Virology. 1997 237(1): 123-128.
  1. 24.   Inactivation of the Human Immunodeficiency Virus Type 1 Inhibitory Elements Allows Rev-Independent Expression of Gag and Gag/Protease and Particle Formation
  2. Schneider, R.; Campbell, M.; Nasioulas, G.; Felber, B. K.; Pavlakis, G. N.
  3. Journal of Virology. 1997 71(7): 4892-4903.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel